Head-to-head · WeighScore
MadeMed vs Rivo Health
By GLP-1 ScorecardUpdated
Score comparison
MadeMed has the higher recorded score — 80.4/100 to 71.7/100.
MadeMed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MadeMed advertises all-dose pricing across 30-, 90- and 360-day purchases, with a consultation-fee conflict to resolve before prepaying.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | MadeMed | Rivo Health |
|---|---|---|
| WeighScore | 80.4/100 | 71.7/100 |
| Grade | B− | C |
| Site position | #23 | #100 |
| Semaglutide | $179 every 30 days; $483/90 days or $1,718/360 days ($143.17 equivalent per 30 days); consultation fees and usable supply require confirmation | $149/mo advertised starting rate on annual plan (compounded; confirm selected charge and renewal) |
| Tirzepatide | Injection or sublingual: $249 every 30 days; $672/90 days or $2,390/360 days ($199.17 equivalent per 30 days); final fees and supply unverified | $199/mo advertised starting rate on annual plan (compounded; confirm selected charge and renewal) |
| Coverage | Confirm selected treatment/state: sublingual tirzepatide FAQ lists 40 states; current injection-state map unverified | State eligibility unverified; confirm prescribing and dispensing availability for your address |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #23 · B−
Strengths
- Public selectors show full charges for 30-, 90- and 360-day plans across the listed GLP-1 products
- Advertises the same pricing across doses, ongoing clinical messaging and included injection supplies
- Current terms name MDI Medical Group PC and four partner pharmacy brands
- A 30-day purchase is advertised alongside the larger prepaid options
What to consider
- Lowest advertised equivalents require $1,718/$2,390 360-day billing plans; terms reject prorated refunds
- Product pages list $20/$30 consultation fees while How It Works says consultation is included and ineligible payments are refunded in full
- The forty-state claim is specific to sublingual tirzepatide; an injection-state map was not established
- Assigned clinician/pharmacy branch, patient lab costs, final first debit and usable prescription supply remain unresolved
Site position #100 · C
Strengths
- Advertises semaglutide and tirzepatide injection and oral options
- Starting-price cards disclose an annual-plan condition
- Advertises provider visits, nutrition support and dietitian access
- Current public pages name Rivo Health, Inc. and a Rimo Health clinical network
What to consider
- The $149/$199 labels are annual-plan starting rates; first charge, total obligation and renewal remain unverified
- The selected cancellation and refund agreement has not been verified
- Exact treating practice, dispensing branch and individual state/license eligibility remain unverified
- Bundled service frequency, lab costs, supplied quantity and extra charges need selected-plan confirmation
Featured provider
MadeMed
MadeMed scores 80.4/100 (B−). MadeMed advertises all-dose pricing across 30-, 90- and 360-day purchases, with a consultation-fee conflict to resolve before prepaying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.